Al-Dawaa Medical Services Company

4163.SRSAUHealthcare● Active

$43.82

+$0.26(+0.60%)

Market Cap$3.7B

P/E Ratio—

52W High$80.05

52W Low$43

Avg Volume223K

Open$43.28

Beta-0.04

Overview

Al-Dawaa Medical Services Company (4163.SR) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

4163.SR · free cash flow · updated Jun 15, 2026

Core FCF metrics

4163.SR · FCF · TTM · margin & CAGR

Free cash flow was $512.2M for FY2025 (fiscal year ending 2025-12-31), up 12.7% year-over-year The FCF margin was 7.6%. Five-year CAGR stands at +25.7%.

FY2025 Free Cash Flow$512.2M▲ +12.7% YoY

Trailing 12M (TTM)$510.9Mtrailing 4 quarters sum

FCF Margin7.6%$512.2M ÷ revenue

3-Year CAGR+1.4%FY2022 → FY2025

5-Year CAGR+25.7%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

4163.SR · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$660.0M(148M)$512.2M▲ +12.7%7.6%

FY2024$683.3M(229M)$454.6M▼ 9.5%7.0%

FY2023$725.7M(224M)$502.1M▲ +2.3%8.8%

FY2022$778.4M(288M)$490.8M▲ +40.2%9.1%

FY2021$670.1M(320M)$350.0M▲ +114.3%7.0%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

4163.SR · P/FCF · FCF yield · FCF per share

Al-Dawaa Medical Services Company (4163.SR) trades at a FCF yield of 13.72% and a price-to-free-cash-flow ratio of 7.3x. FCF per share stands at $6.02, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

13.72%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$6.02

TTM FCF ÷ Shares Outstanding

Price / FCF

x7.3

Share Price ÷ FCF per Share

EV / FCF (TTM)

x11.6

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

4163.SR · cash flow statement · operating / investing / financing

For FY2025, Al-Dawaa Medical Services Company generated $660.0M in operating cash flow and spent 148M in capital expenditures, yielding $512.2M in free cash flow.

Operating Activities

+$660.0M

Cash from core business operations

2025-12-31

Investing Activities

−$163.8M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$472.5M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($660.0M) − |CapEx| (148M) = FCF ($512.2M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

4163.SR vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Al-Dawaa Medical Services CompanyYOU

4163.SR

$512.2M+12.7%7.6%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Al-Dawaa Medical Services Company (4163.SR) reported free cash flow of $512.2M for FY2025 (fiscal year ending 2025-12-31), up 12.7% year-over-year. The FCF margin was 7.6%.

Based on available data, Al-Dawaa Medical Services Company has maintained positive free cash flow for at least 9 fiscal year(s). FCF peaked at $512.2M in FY2025. The 5-year CAGR stands at +25.7%.

Al-Dawaa Medical Services Company's FCF yield is 13.72% and price-to-FCF ratio is 7.3x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

4163.SR free cash flow · 8 questions

Al-Dawaa Medical Services Company free cash flow was $512.2M for FY2025, up 12.7% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $510.9M.

4163.SR free cash flow4163.SR FCF4163.SR FCF 20254163.SR free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Al-Dawaa Medical Services Company · Al-Dawaa Medical Services Company SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026